ANCA disease: where is this field heading?

Area of Science:

• Immunology
• Nephrology
• Rheumatology

Background:

• Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitides and glomerulonephritides are of significant clinical and research interest.
• Classification and nomenclature for ANCA-associated diseases remain under discussion.
• Despite classification challenges, overlapping disease categories often share similar therapeutic strategies.

Purpose of the Study:

• To examine current understanding of ANCA-associated diseases.
• To discuss the immunopathogenesis, including the role of myeloperoxidase and proteinase 3 antibodies.
• To explore emerging mechanisms of disease initiation, such as autoantigen complementarity.
• To propose an approach to treatment for ANCA-associated diseases.

Main Methods:

• Literature review of experimental and clinical studies on ANCA diseases.
• Analysis of immunopathogenic mechanisms involving specific antibodies.
• Examination of factors contributing to disease initiation.
• Discussion of current and proposed treatment strategies.

Main Results:

• Established immunopathogenic roles of myeloperoxidase (MPO) and proteinase 3 (PR3) antibodies.
• Emerging evidence for autoantigen complementarity in disease initiation.
• Recognition of shared characteristics and treatment approaches across ANCA disease subtypes.

Conclusions:

• ANCA-associated diseases, though complex in classification, share key features and therapeutic principles.
• Understanding immunopathogenesis, particularly autoantigen complementarity, is crucial for effective treatment.
• A comprehensive approach integrating current knowledge is essential for managing ANCA diseases.